Genmab A/S (GMAB) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $40.00 price target on the stock.
Transactions in Connection with Share Buy-back Program [Yahoo! Finance]
Is Genmab (CPSE:GMAB) Pricing Look Attractive After Recent Share Price Weakness [Yahoo! Finance]
Genmab (CPSE:GMAB) Valuation Check After Recent Share Price Weakness [Yahoo! Finance]
Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab [Yahoo! Finance]